Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2022 · 10-Q
Revenue$11.82B$11.82B+19.3% vs Q1 2021 Net Income$2.22B$2.22B−5.0% vs Q1 2021 EPS Diluted$5.61$5.61−4.6% vs Q1 2021 Operating Income$2,821,000,000−7.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Free Cash Flowderived$1,562,000,000+15.7% Margins · derivedOperating margin23.9%−6.9 pt vs Q1 2021
Net margin18.8%−4.8 pt vs Q1 2021
ended Apr 2, 2022 · filed May 6, 2022 · 34 d after period end